Indaptus Therapeutics, Inc. INDP
NASDAQ · United States · Health Technology
$2.38+0.26 (+12.26%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.02 | -1.57 | +98.7% | +4.9%$1.02→$1.07 |
| Q4 2025 | 2026-03-17 | -9.19 | -4.36 | -110.8% | +6.9%$1.75→$1.87 |
| Q3 2025 | 2025-11-12 | -2.98 | -4.17 | +28.5% | +8.8%$2.72→$2.96 |
| Q2 2025 | 2025-08-13 | -9.09 | -9.24 | +1.6% | — |
| Q1 2025 | 2025-05-14 | -8.96 | -5.04 | -77.8% | — |
| Q4 2024 | 2025-03-13 | -10.64 | -11.48 | +7.3% | — |
| Q2 2024 | 2024-08-12 | -13.16 | -15.40 | +14.5% | — |
| Q4 2023 | 2024-03-13 | -13.16 | -15.12 | +13.0% | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.